Treatment of GC cell lines with everolimus promotes decreased phosphorylation of S6K1 and 4E-BP1, induces G1 cell cycle arrest, and inhibits the proliferation of GC cells. This evidence concerns the gene EIF4EBP1 and gastric cancer.